A clear brand, investor-ready website, and restructured pitch helped BioLattice build early momentum as it prepared for its seed round.

— Brand Strategy and Identity

— Investor-ready Website

— Pitch Deck Narrative and Design

BioLattice Ophthalmics is developing a novel approach to corneal repair. As the team prepared to raise its seed round, the science was strong but the story was not yet investor-ready.

Through the Radian Grant, we helped translate their clinical innovation into a brand, website, and pitch narrative that could hold up under investor scrutiny.

Update!

BioLattice adds another win to its growing list of pitch competition victories →

A brand rooted in the science

BioLattice's technology restores clarity to patients with corneal blindness. The identity we designed reflects that directly: a logo that resolves from blur into a lattice-inspired pattern, paired with a precise, light-driven color palette. Every visual choice connects to the clinical science, not decoration.

BioLattice's technology restores clarity to patients with corneal blindness. The identity we designed reflects that directly: a logo that resolves from blur into a lattice-inspired pattern, paired with a precise, light-driven color palette. Every visual choice connects to the clinical science, not decoration.

"Radian impressed us with their deep understanding of biotech. Their strategic redesign of our brand, website, and pitch deck has led to a noticeable increase in investor engagement. We couldn’t be happier with the results."

Amelia Zellander, PhD, co-founder of BioLattice

Amelia Zellander, PhD
Co-Founder & CSO

Pitch materials built on scientific clarity

We restructured the pitch deck around a clear information hierarchy, replacing dense technical slides with visuals that communicate the science without oversimplifying it.

By framing the limitations of donor transplants, from low availability to high graft failure rates, we helped investors quickly understand the unmet need and the strength of BioLattice's approach.

We restructured the pitch deck around a clear information hierarchy, replacing dense technical slides with visuals that communicate the science without oversimplifying it.

By framing the limitations of donor transplants, from low availability to high graft failure rates, we helped investors quickly understand the unmet need and the strength of BioLattice's approach.

"Radian impressed us with their deep understanding of biotech. Their strategic redesign of our brand, website, and pitch deck has led to a noticeable increase in investor engagement. We couldn’t be happier with the results."

Amelia Zellander, PhD
Co-Founder & CSO

BioLattice website screen with the headline “Revolutionizing Cornea Repair”

info@weareradian.com